The Federal Circuit has preserved patent-eligibility for medical diagnostics testing, finding that the administration of drugs and determination of resulting chemical levels can meet the machine-or-transformation test set forth in In re Bilski. In Prometheus Labs, Inc. v. Mayo Collaborative Servs., 581 F.3d 1336 (Fed. Cir. 2009), the U.S. Court…

Disclaimer: Legal advice can only be properly given by a lawyer with knowledge of all of the relevant facts. None of the foregoing, or of any other portion of LawUpdates.com, constitutes legal advice. None of LawUpdates.com, LLC and the attorneys and other persons contributing content to LawUpdates.com are liable in any way for your use of any of the information found on this page or anywhere else on LawUpdates.com. If you are in need of legal advice, contact an attorney experienced in the relevant area of law.